Valerio Therapeutics
innovative synthetic antibody therapies
- B2B
About Valerio Therapeutics
Development of synthetic single-domain antibody therapies with deep tissue penetration for complex diseases, focusing on rapid clinical advancement and strategic partnerships.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51–250 employees
- Headquarters
- Villejuif, Île-de-France, France
- Founded
- 2014
- Revenue
- €2.6MFY2025, filed accounts, INPI
- Website
- valeriotx.com
- linkedin.com/company/valerio-tx
Valerio Therapeutics at a glance
Valerio Therapeutics is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Villejuif, Île-de-France, France.
Valerio Therapeutics was founded in 2014.
Valerio Therapeutics has 51–250 employees.
Valerio Therapeutics's revenue is €2.6M (FY2025, filed accounts, INPI).
Frequently asked questions about Valerio Therapeutics
What is Valerio Therapeutics's revenue?
Valerio Therapeutics's revenue is €2.6M (FY2025, filed accounts, INPI).
How many employees does Valerio Therapeutics have?
Valerio Therapeutics has 51–250 employees.
Where is Valerio Therapeutics headquartered?
Valerio Therapeutics is headquartered in Villejuif, Île-de-France, France.
Selling to companies like Valerio Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies